{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T18:41:22Z","timestamp":1683484882132},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1007\/s00115-006-2096-9","type":"journal-article","created":{"date-parts":[[2006,6,13]],"date-time":"2006-06-13T11:26:33Z","timestamp":1150197993000},"page":"1310-1322","source":"Crossref","is-referenced-by-count":1,"title":["Behandlungsm\u00f6glichkeiten der akuten Manie mit atypischen Antipsychotika","Treatment options for bipolar mania"],"prefix":"10.1007","volume":"77","author":[{"given":"T.","family":"Attarbaschi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2096_CR1","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","volume":"156","author":"Allison","year":"1999","unstructured":"Allison DB, Mentore JL, Heo M et al. (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156:1686\u20131696","journal-title":"Am J Psychiatry"},{"key":"2096_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.ajp.159.1.1","volume":"159","author":"American","year":"2002","unstructured":"American Psychiatric Association (2002) Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159:1\u201350","journal-title":"Am J Psychiatry"},{"key":"2096_CR3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1192\/bjp.185.6.472","volume":"185","author":"Baker","year":"2004","unstructured":"Baker RW, Brown E, Akiskal HS et al. (2004) Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. Br J Psychiatry 185:472\u2013478","journal-title":"Br J Psychiatry"},{"key":"2096_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.v60n0104","volume":"60","author":"Bauer","year":"1999","unstructured":"Bauer MS, Callahan AM, Jampala C et al. (1999) Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J Clin Psychiatry 60:9\u201321","journal-title":"J Clin Psychiatry"},{"key":"2096_CR5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-9964(02)00431-0","volume":"62","author":"Bobes","year":"2003","unstructured":"Bobes J, Rejas J, Garcia-Garcia M et al. (2003) Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study. Schizophr Res 62:77\u201388","journal-title":"Schizophr Res"},{"key":"2096_CR6","unstructured":"Bowden CL (2000) Efficacy of lithium in mania and maintenance therapy of bipolar disorder. J Clin Psychiatry 61(Suppl\u00a09):35\u201340"},{"key":"2096_CR7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","volume":"66","author":"Bowden","year":"2005","unstructured":"Bowden CL, Grunze H, Mullen J et al. (2005) A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 66:111\u2013121","journal-title":"J Clin Psychiatry"},{"key":"2096_CR8","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1176\/ajp.156.9.1417","volume":"156","author":"Cassidy","year":"1999","unstructured":"Cassidy F, Ahearn E, Carroll BJ (1999) Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 156:1417\u20131420","journal-title":"Am J Psychiatry"},{"key":"2096_CR9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1176\/ajp.133.8.905","volume":"133","author":"Dunner","year":"1976","unstructured":"Dunner DL, Fleiss JL, Fieve RR (1976) The course of development of mania in patients with recurrent depression. Am J Psychiatry 133:905\u2013908","journal-title":"Am J Psychiatry"},{"key":"2096_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4088\/JCP.v61n0306","volume":"61","author":"Elmslie","year":"2000","unstructured":"Elmslie JL, Silverstone JT, Mann JI et al. (2000) Prevalence of overweight and obesity in bipolar patients. J Clin Psychiatry 61:179\u2013184","journal-title":"J Clin Psychiatry"},{"key":"2096_CR11","unstructured":"Fan AH, Frye MA, Masseling SJ et al. (2002) Alcohol abuse increases suicidalitiy and psychosis in mania. Poster presented at the Annual meeting of the American Psychiatric Association, May 18\u201323 2002, Philadelphia, PA (NR 13)"},{"key":"2096_CR12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000061663","volume":"25","author":"Frye","year":"1997","unstructured":"Frye MA, Altshuler LL (1997) Selection of initial treatment for bipolar disorder, manic phase. Mod Probl Pharmacopsychiatry 25:88\u2013113","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"2096_CR13","unstructured":"Gaebel W, Falkai P (2000) Behandlungsleitlinie Affektive Erkrankungen. Praxisleitlinien in Psychiatrie und Psychotherapie, Bd\u00a05. Steinkopff, Darmstadt"},{"key":"2096_CR14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0327(02)00070-8","volume":"76","author":"Gonzalez-Pinto","year":"2003","unstructured":"Gonzalez-Pinto A, Ballesteros J, Aldama A et al. (2003) Principal components of mania. J Affect Disord 76:95\u2013102","journal-title":"J Affect Disord"},{"key":"2096_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881103017002003","volume":"17","author":"Goodwin","year":"2003","unstructured":"Goodwin GM (2003) Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17:149\u2013173","journal-title":"J Psychopharmacol"},{"key":"2096_CR16","unstructured":"Goodwin F, Jamison K (1990) Manic-depressive Illness. Oxford University Press, New York"},{"key":"2096_CR17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/15622970309167904","volume":"4","author":"Grunze","year":"2003","unstructured":"Grunze H, Kasper S, Goodwin G et al. (2003) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: treatment of mania world. J Biol Psychiatry 4:5\u201313","journal-title":"J Biol Psychiatry"},{"key":"2096_CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4088\/JCP.v64n0111","volume":"64","author":"Hirschfeld","year":"2003","unstructured":"Hirschfeld RM, Calabrese JR, Weissman MM et al. (2003) Screening for bipolar disorder in the community. J Clin Psychiatry 64:53\u201359","journal-title":"J Clin Psychiatry"},{"key":"2096_CR19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","volume":"161","author":"Hirschfeld","year":"2004","unstructured":"Hirschfeld RM, Keck PE Jr, Kramer M et al. (2004) Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiatry 161:1057\u20131065","journal-title":"Am J Psychiatry"},{"key":"2096_CR20","doi-asserted-by":"crossref","unstructured":"Kasper S (2003) Issues in the treatment of bipolar disorder. Eur Neuropsychopharmacol 13(Suppl\u00a02):S37\u2013S42","DOI":"10.1016\/S0924-977X(03)00076-2"},{"key":"2096_CR21","unstructured":"Kasper S, Klein N (2003) Die Nase vorn. Neue Entwicklungen in der Therapie mit Antipsychotika\/Neuroleptika belegen die Vorteile der Atypika. Neuro-Psychiatr Nachri 5"},{"key":"2096_CR22","doi-asserted-by":"crossref","unstructured":"Kasper S, Resinger E (2003) Cognitive effects and antipsychotic treatment. Psychoneuroendocrinology 28 [Suppl\u00a01]:27\u201338","DOI":"10.1016\/S0306-4530(02)00115-4"},{"key":"2096_CR23","first-page":"25","volume":"3","author":"Kasper","year":"2004","unstructured":"Kasper S, Attarbaschi T (2004) Treatment options for bipolar mania. Clin Approach Bipol Disord 3:25\u201333","journal-title":"Clinical Approaches in Bipolar Disorders"},{"key":"2096_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004850-200206001-00001","volume":"17","author":"Kasper","year":"2002","unstructured":"Kasper S, Stamenkovic M, Letmaier M et al. (2002) Atypical antipsychotics in mood disorders. Int Clin Psychopharmacol 17:1\u201310","journal-title":"Int Clin Psychopharmacol"},{"key":"2096_CR25","unstructured":"Kasper S, Tauscher J, Aschauer H et al. (2003) Bipolare St\u00f6rungen-Medikament\u00f6se Therapie. State of the art 2003. Clini Cum Sonderausgabe 11\/2003"},{"key":"2096_CR26","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1097\/00004714-199604001-00003","volume":"16","author":"Keck","year":"1996","unstructured":"Keck PE Jr., McElroy SL (1996) Outcome in the pharmacologic treatment of bipolar disorder. J Clin Psychopharmacol 16:15S\u201323S","journal-title":"J Clin Psychopharmacol"},{"key":"2096_CR27","unstructured":"Keck PE Jr., McElroy SL, Strakowski SM (1998) Anticonvulsants and antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry 59(Suppl\u00a06):74\u201381"},{"key":"2096_CR28","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","volume":"160","author":"Keck","year":"2003","unstructured":"Keck PE Jr., Marcus R, Tourkodimitris S et al. (2003) A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 160:1651\u20131658","journal-title":"Am J Psychiatry"},{"key":"2096_CR29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","volume":"160","author":"Keck","year":"2003","unstructured":"Keck PE Jr., Versiani M, Potkin S et al. (2003) Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 160:741\u2013748","journal-title":"Am J Psychiatry"},{"key":"2096_CR30","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1017\/S0033291797005333","volume":"27","author":"Kessler","year":"1997","unstructured":"Kessler RC, Rubinow DR, Holmes C et al. (1997) The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med 27:1079\u20131089","journal-title":"Psychol Med"},{"key":"2096_CR31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.187.3.229","volume":"187","author":"Khanna","year":"2005","unstructured":"Khanna S, Vieta E, Lyons B et al. (2005) Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry 187:229\u2013234","journal-title":"Br J Psychiatry"},{"key":"2096_CR32","unstructured":"Kusumakar V, Yatham LN, Haslam DR et al. (1997) Treatment of mania, mixed state, and rapid cycling. Can J Psychiatry 42(Suppl\u00a02):79S\u201386S"},{"key":"2096_CR33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00115-003-1554-x","volume":"75","author":"Letmaier","year":"2004","unstructured":"Letmaier M, Schreinzer D, Thierry N et al. (2004) Medikament\u00f6se Behandlung akuter Manien. Eine retrospektive Datenanalyse station\u00e4rer Patienten von 1997 bis 1999. Nervenarzt 75:249\u2013257","journal-title":"Nervenarzt"},{"key":"2096_CR34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1399-5618.2001.30401.x","volume":"3","author":"Lim","year":"2001","unstructured":"Lim PZ, Tunis SL, Edell WS et al. (2001) Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines. Bipolar Disord 3:165\u2013173","journal-title":"Bipolar Disord"},{"key":"2096_CR35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4088\/JCP.v63n0306","volume":"63","author":"McElroy","year":"2002","unstructured":"McElroy SL, Frye MA, Suppes T et al. (2002) Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 63:207\u2013213","journal-title":"J Clin Psychiatry"},{"key":"2096_CR36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2005.02.006","volume":"15","author":"McIntyre","year":"2005","unstructured":"McIntyre RS, Brecher M, Paulsson B et al. (2005) Quetiapine or haloperidol as monotherapy for bipolar mania-a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol 15:573\u2013585","journal-title":"Eur Neuropsychopharmacol"},{"key":"2096_CR37","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archpsyc.60.9.904","volume":"60","author":"Miklowitz","year":"2003","unstructured":"Miklowitz DJ, George EL, Richards JA et al. (2003) A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry 60:904\u2013912","journal-title":"Arch Gen Psychiatry"},{"key":"2096_CR38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.jcp.0000169068.34322.70","volume":"25","author":"Potkin","year":"2005","unstructured":"Potkin SG, Keck PE Jr, Segal S et al. (2005) Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol 25:301\u2013310","journal-title":"J Clin Psychopharmacol"},{"key":"2096_CR39","first-page":"1","volume":"No","author":"Sachs","year":"2000","unstructured":"Sachs GS, Printz DJ, Kahn DA et al. (2000) The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med Spec No:1\u2013104","journal-title":"Postgrad Med Spec"},{"key":"2096_CR40","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","volume":"159","author":"Sachs","year":"2002","unstructured":"Sachs GS, Grossman F, Ghaemi SN et al. (2002) Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 159:1146\u20131154","journal-title":"Am J Psychiatry"},{"key":"2096_CR41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","volume":"6","author":"Sachs","year":"2004","unstructured":"Sachs G, Chengappa K, Suppes T et al. (2004) Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 6:213\u2013223","journal-title":"Bipolar Disord"},{"key":"2096_CR42","first-page":"a","volume":"disorder","author":"Sachs","year":"2006","unstructured":"Sachs G, Sanchez R, Marcus R et al. (2006) Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Pyschopharmacol, (Epub ahead of print)","journal-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I"},{"key":"2096_CR43","first-page":"176","volume":"21","author":"Segal","year":"1998","unstructured":"Segal J, Berk M, Brook S (1998) Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 21:176\u2013180","journal-title":"Clin Neuropharmacol"},{"key":"2096_CR44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/appi.ajp.159.4.561","volume":"159","author":"Sernyak","year":"2002","unstructured":"Sernyak MJ, Leslie DL, Alarcon RD et al. (2002) Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 159:561\u2013566","journal-title":"Am J Psychiatry"},{"key":"2096_CR45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2004.06.003","volume":"15","author":"Smulevich","year":"2005","unstructured":"Smulevich AB, Khanna S, Eerdekens M et al. (2005) Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur Neuropsychopharmacol 15:75\u201384","journal-title":"Eur Neuropsychopharmacol"},{"key":"2096_CR46","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4088\/JCP.v63n0404","volume":"63","author":"Suppes","year":"2002","unstructured":"Suppes T, Dennehy EB, Swann AC et al. (2002) Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. J Clin Psychiatry 63:288\u2013299","journal-title":"J Clin Psychiatry"},{"key":"2096_CR47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.1997.01830130041008","volume":"54","author":"Swann","year":"1997","unstructured":"Swann AC, Bowden CL, Morris D et al. (1997) Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 54:37\u201342","journal-title":"Arch Gen Psychiatry"},{"key":"2096_CR48","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","volume":"156","author":"Tohen","year":"1999","unstructured":"Tohen M, Sanger TM, McElroy SL et al. (1999) Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study group. Am J Psychiatry 156:702\u2013709","journal-title":"Am J Psychiatry"},{"key":"2096_CR49","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","volume":"57","author":"Tohen","year":"2000","unstructured":"Tohen M, Jacobs TG, Grundy SL et al. (2000) Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry 57:841\u2013849","journal-title":"Arch Gen Psychiatry"},{"key":"2096_CR50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","volume":"59","author":"Tohen","year":"2002","unstructured":"Tohen M, Chengappa KN, Suppes T et al. (2002) Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 59:62\u201369","journal-title":"Arch Gen Psychiatry"},{"key":"2096_CR51","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","volume":"60","author":"Tohen","year":"2003","unstructured":"Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM et al. (2003) A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch Gen Psychiatry 60:1218\u20131226","journal-title":"Arch Gen Psychiatry"},{"key":"2096_CR52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1192\/bjp.182.2.141","volume":"182","author":"Yatham","year":"2003","unstructured":"Yatham LN, Grossman F, Augustyns I et al. (2003) Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry 182:141\u2013147","journal-title":"Br J Psychiatry"},{"key":"2096_CR53","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/01.jcp.0000144887.66319.2f","volume":"24","author":"Yatham","year":"2004","unstructured":"Yatham LN, Paulsson B, Mullen J et al. (2004) Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 24:599\u2013606","journal-title":"J Clin Psychopharmacol"},{"key":"2096_CR54","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1185\/030079905X46340","volume":"21","author":"Vieta","year":"2005","unstructured":"Vieta E, Mullen J, Brecher M et al. (2005) Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Curr Med Res Opin 21:923\u2013934","journal-title":"Curr Med Res Opin"},{"key":"2096_CR55","first-page":"115","volume":"6","author":"Walden","year":"1999","unstructured":"Walden J, Grunze H, Schl\u00f6sser S et al. (1999) Empfehlungen f\u00fcr die Behandlung bipolarer affektiver St\u00f6rungen. Psychopharmakotherapie 6:115\u2013122","journal-title":"Psychopharmakotherapie"},{"key":"2096_CR56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0165-0327(87)90049-8","volume":"13","author":"Weeke","year":"1987","unstructured":"Weeke A, Juel K, Vaeth M (1987) Cardiovascular death and manic-depressive psychosis. J Affect Disord 13:287\u2013292","journal-title":"J Affect Disord"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-006-2096-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-006-2096-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-006-2096-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T18:20:49Z","timestamp":1683483649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-006-2096-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["2096"],"URL":"https:\/\/doi.org\/10.1007\/s00115-006-2096-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}